FDA Inspection
Shilpa Medicare LimitedShilpa Medicare Limited – FDA Inspection, Nov 30, 2017
Record Details
This FDA Inspection record concerns Shilpa Medicare Limited, with an inspection on November 30, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 11c5330b-3d05-4b5e-9662-f17cadc816a0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1036712
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shilpa Medicare Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | Not classified | Office of Inspections and Investigations | |
| November 9, 2023 | Not classified | Office of Inspections and Investigations | |
| February 25, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shilpa Medicare Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.